{"id":51437,"date":"2012-08-21T22:11:15","date_gmt":"2012-08-21T22:11:15","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/new-marker-for-identifying-precursors-to-insulin-producing-cells-in-pancreas.php"},"modified":"2012-08-21T22:11:15","modified_gmt":"2012-08-21T22:11:15","slug":"new-marker-for-identifying-precursors-to-insulin-producing-cells-in-pancreas","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/new-marker-for-identifying-precursors-to-insulin-producing-cells-in-pancreas.php","title":{"rendered":"New marker for identifying precursors to insulin-producing cells in pancreas"},"content":{"rendered":"<p><p>Public  release date: 21-Aug-2012  [ |   E-mail   |  Share    ]  <\/p>\n<p>    Contact: Vicki Cohn    <a href=\"mailto:vcohn@liebertpub.com\">vcohn@liebertpub.com<\/a>    914-740-2100 x2156    Mary    Ann Liebert, Inc.\/Genetic Engineering News<\/p>\n<p>    New Rochelle, NY, August 21, 2012For the millions of people    worldwide with type 1 diabetes who cannot produce sufficient    insulin, the potential to transplant insulin-producing cells    could offer hope for a long-term cure. The discovery of a    marker to help identify and isolate stem cells that can develop    into insulin-producing cells in the pancreas would be a    critical step forward and is described in an article in    BioResearch Open Access, a new bimonthly peer-reviewed    open access journal from Mary Ann Liebert, Inc. (<a href=\"http:\/\/www.liebertpub.com\" rel=\"nofollow\">http:\/\/www.liebertpub.com<\/a>) The    article is available free online at the BioResearch Open    Access website (<a href=\"http:\/\/www.liebertpub.com\/biores\" rel=\"nofollow\">http:\/\/www.liebertpub.com\/biores<\/a>).  <\/p>\n<p>    Pancreatic stem cells, the precursors of insulin-producing    cells, have not yet been identified in humans or animals, and    there is much debate about where they may reside. Ivka    Afrikanova, Ayse Kayali, Ana Lopez, and Alberto Hayek,    University of California, San Diego, CA, have identified a    biochemical markerstage-specific embryonic antigen 4    (SSEA4)that they propose can be used to identify and purify    human pancreatic stem cells. The article \"Is Stage-Specific    Embryonic Antigen 4 a Marker for Human Ductal Stem\/Progenitor    Cells\" (<a href=\"http:\/\/online.liebertpub.com\/doi\/full\/10.1089\/biores.2012.0235\" rel=\"nofollow\">http:\/\/online.liebertpub.com\/doi\/full\/10.1089\/biores.2012.0235<\/a>)    reports that when grown in culture with high levels of glucose    and B27, these SSEA4+ stem cells can differentiate into    insulin-producing pancreatic cells.  <\/p>\n<p>    ###  <\/p>\n<p>    About the Journal  <\/p>\n<p>    BioResearch Open Access (<a href=\"http:\/\/www.liebertpub.com\/biores\" rel=\"nofollow\">http:\/\/www.liebertpub.com\/biores<\/a>)    is a bimonthly peer-reviewed open access journal that provides    a new rapid-publication forum for a broad range of scientific    topics including molecular and cellular biology, tissue    engineering and biomaterials, bioengineering, regenerative    medicine, stem cells, gene therapy, systems biology, genetics,    biochemistry, virology, microbiology, and neuroscience. All    articles are published within 4 weeks of acceptance and are    fully open access and posted on PubMedCentral. All journal    content is available online at the BioResearch Open    Access website (<a href=\"http:\/\/www.liebertpub.com\/biores\" rel=\"nofollow\">http:\/\/www.liebertpub.com\/biores<\/a>).  <\/p>\n<p>    About the Publisher  <\/p>\n<p>    Mary Ann Liebert, Inc., publishers (<a href=\"http:\/\/www.liebertpub.com\" rel=\"nofollow\">http:\/\/www.liebertpub.com<\/a>) is a    privately held, fully integrated media company known for    establishing authoritative peer-reviewed journals in many    promising areas of science and biomedical research, including    Tissue Engineering, Stem Cells and Development, Human Gene    Therapy and HGT Methods, and AIDS Research and Human    Retroviruses. Its biotechnology trade magazine, Genetic    Engineering & Biotechnology News (GEN), was the first    in its field and is today the industry's most widely read    publication worldwide. A complete list of the firm's 70    journals, books, and newsmagazines is available at the Mary Ann    Liebert, Inc. website (<a href=\"http:\/\/www.liebertpub.com\" rel=\"nofollow\">http:\/\/www.liebertpub.com<\/a>).  <\/p>\n<p>    Mary Ann Liebert, Inc.    140 Huguenot St., New Rochelle, NY 10801-5215    <a href=\"http:\/\/www.liebertpub.com\" rel=\"nofollow\">http:\/\/www.liebertpub.com<\/a>    Phone: (914) 740-2100    (800) M-LIEBERT    Fax: (914) 740-2101  <\/p>\n<\/p>\n<p>Link: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2012-08\/mali-nmf082112.php\" title=\"New marker for identifying precursors to insulin-producing cells in pancreas\">New marker for identifying precursors to insulin-producing cells in pancreas<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Public release date: 21-Aug-2012 [ | E-mail | Share ] Contact: Vicki Cohn <a href=\"mailto:vcohn@liebertpub.com\">vcohn@liebertpub.com<\/a> 914-740-2100 x2156 Mary Ann Liebert, Inc.\/Genetic Engineering News New Rochelle, NY, August 21, 2012For the millions of people worldwide with type 1 diabetes who cannot produce sufficient insulin, the potential to transplant insulin-producing cells could offer hope for a long-term cure. The discovery of a marker to help identify and isolate stem cells that can develop into insulin-producing cells in the pancreas would be a critical step forward and is described in an article in BioResearch Open Access, a new bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/new-marker-for-identifying-precursors-to-insulin-producing-cells-in-pancreas.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[3],"tags":[],"class_list":["post-51437","post","type-post","status-publish","format-standard","hentry","category-genetic-engineering"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/51437"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=51437"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/51437\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=51437"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=51437"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=51437"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}